Using tDCS in Speech-based Stroke Rehabilitation

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS provides low intensity neural stimulation which has been shown to facilitate motor learning in other domains of stroke rehabilitation such as arm motor learning but the potential to enhance speech motor learning has not been explored. This will be examined with a series of single-case experimental designs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Right-handed

• Monolingual (English)

• Single left-hemisphere CVA

• A minimum of six months post-stroke

• Clinical diagnosis of apraxia of speech

• Normal speech perception

• Passing score on the hearing screening.

Locations
United States
New York
New York University School of Medicine
RECRUITING
New York
Burke Rehabilitation Hospital
RECRUITING
White Plains
Contact Information
Primary
Buchwald Lab
buchwald-lab@nyu.edu
Time Frame
Start Date: 2019-01-11
Estimated Completion Date: 2026-10-30
Participants
Target number of participants: 24
Treatments
Experimental: Active Stimulation
crossover design such that each participant receives behavioral treatment twice - once with active stimulation and once with sham stimulation - in order to evaluate differences in improvement based on treatment condition.
Sham_comparator: Sham Stimulation
crossover design such that each participant receives behavioral treatment twice - once with active stimulation and once with sham stimulation - in order to evaluate differences in improvement based on treatment condition.
Authors
Adam Buchwald
Related Therapeutic Areas
Sponsors
Leads: NYU Langone Health
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials